Analystreport

Evolent Health (NYSE:EVH) had its price target lowered by analysts at BTIG Research from $20.00 to $16.00. They now have a "buy" rating on the stock.

Evolent Health, Inc Class A  (EVH) 
Last evolent health, inc class a earnings: 2/25 04:02 pm Check Earnings Report
US:NYSE Investor Relations: ir.evolenthealth.com